2000 patients join effort to unravel mysteries of stomach and gut disorders

NCT ID NCT04918329

Recruiting now Knowledge-focused Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is following 2000 adults with functional digestive disorders like irritable bowel syndrome, dyspepsia, and constipation. Researchers will collect medical data and biological samples (biopsies, blood, urine, stool) during routine care. The goal is to find markers that could lead to better diagnosis and personalized treatments for these common but poorly understood conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better diagnose and personalize treatment for common digestive problems like IBS and dyspepsia.
What could go wrong: This is an observational study, not a treatment trial. It collects information but does not test a new therapy, so direct patient benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ABDOMINAL PAIN (AP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Abdominal Pain constipation disorder cyclic vomiting syndrome dyspepsia Encopresis functional diarrhea gastroesophageal reflux disease irritable bowel syndrome opioid-induced constipation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ABDOMINAL PAIN (AP) DYSPEPSIA FAECAL INCONTINENCE FUNCTIONAL CONSTIPATION IRRITABLE BOWEL SYNDROME VOMITING SYNDROME

Contacts and locations

Locations

Physiology Unit, Hopital Charles Nicolle, 1 rue de Germont
RECRUITING

Rouen, 76031, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.